YDB-102

N/A

Report date: 2023/12/18 18:08:15

Base Information

Drug NameYDB-102
Drug Alias NameYDB-102
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionOxidoreductases inhibitors
TargetsOxidoreductases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYd Global Life Science Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYd Global Life Science Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A